Hematology & Blood Cancer

Why Choose Our Hematology & Blood Cancer Department?

Cleveland Clinic Abu Dhabi’s Hematology & Blood Cancer Department provides specialized care and support for people diagnosed with malignant and non-malignant blood disorders, including leukemia, lymphoma and multiple myeloma, as well as hereditary blood disorders, anemias, bleeding and clotting disorders and bone marrow disorders.

Our department has access to the latest developments in blood cancer diagnostics and treatment options. We offer advanced precision oncology, an approach to treating cancer that is targeted to the individual and their disease, as well as the very latest in molecular testing, including next generation sequencing, a technique which allows doctors to analyze a patient’s unique genetic features. Our specialists use a multidisciplinary approach to develop individualized treatment plans, recognizing that conditions affecting plasma cells can require very different approaches to care. This includes expertise in rare plasma cell disorders such as POEMS syndrome. We also offer the latest treatment modalities, including advanced immunotherapies like Bispecific T-cell Engager (BiTE) therapy, which are significantly improving quality of life and survival rates for many blood cancer patients, in addition to chemotherapy, immunotherapy and targeted therapy.

Every patient who visits the Hematology & Blood Cancer Program has a dedicated team of medical experts to support them, and their family, throughout their treatment journey. The multidisciplinary team round daily to discuss each patient’s needs, their progress and to decide the best treatment plan. We work closely with our team of experts at Cleveland Clinic in the US when needed, one of the largest and most respected hematology and blood cancer programs in the world, and home to one of the country’s only rare blood cancer clinics.